外汇衍生品交易
Search documents
深天马A: 外汇衍生品交易业务管理制度(2025年8月)
Zheng Quan Zhi Xing· 2025-08-22 12:12
天马微电子股份有限公司 外汇衍生品交易业务管理制度 第三条 公司开展外汇衍生品交易业务只允许与经国家外汇管理总局和中 国人民银行批准、具有外汇衍生品交易业务经营资格的金融机构进行交易,不得 与前述金融机构之外的其他组织或个人进行交易。 第四条 公司进行外汇衍生品交易必须基于公司的外币收(付)款的谨慎预 测,外汇衍生品交易合约的外币金额不得超过外币收(付)款的谨慎预测量。外 汇衍生品交易的交割期间需与公司预测的外币回款时间相匹配,持仓时间一般不 得超过 12 个月或实货合同规定时间。 (2025 年 8 月修订) 第一章 总 则 为规范天马微电子股份有限公司(以下简称"公司")外汇衍生品交易业务及 相关信息披露工作,加强对外汇衍生品交易业务的管理,防范投资风险,健全和 完善公司外汇衍生品交易业务管理机制,确保公司资产安全,根据《中华人民共 和国公司法》《中华人民共和国证券法》《深圳证券交易所股票上市规则》《上 市公司信息披露管理办法》及《公司章程》等有关规定,结合公司实际情况,特 制定本制度。 第一条 本制度所指外汇衍生品业务主要是以汇率为标的资产的远期合约、 掉期业务为套期工具,旨在为降低主业范围内风险敞口而 ...
中际联合:拟增外汇衍生品交易额度至1.25亿美元
Xin Lang Cai Jing· 2025-08-22 07:57
Core Points - The company, Zhongji United (Beijing) Technology Co., Ltd., has proposed to increase its foreign exchange derivatives trading limit from a maximum of 35 million USD (or equivalent foreign currency) to a maximum of 125 million USD (or equivalent foreign currency) [1] - The proposal is subject to approval by the shareholders' meeting [1] - The increased trading limit will allow the company and its subsidiaries to use the funds in a rolling manner, utilizing their own capital [1]
润丰股份: 外汇衍生品交易业务管理制度
Zheng Quan Zhi Xing· 2025-08-21 16:59
Core Points - The company has established a set of regulations to manage foreign exchange derivative trading, ensuring compliance with relevant laws and safeguarding asset security [1][8] - The foreign exchange derivative trading activities are aimed at hedging against currency and interest rate risks, and must not involve speculation or arbitrage [2][3] - All foreign exchange derivative transactions must be conducted with qualified financial institutions approved by the State Administration of Foreign Exchange and the People's Bank of China [2][3] Summary by Sections Chapter 1: General Provisions - The regulations are designed to standardize the company's foreign exchange derivative trading and related information disclosure [1] - The term "foreign exchange derivative trading" includes various financial instruments used to mitigate currency and interest rate risks [1] Chapter 2: Operating Principles and Procedures - The company must adhere to principles of legality, prudence, safety, and effectiveness in foreign exchange derivative trading [2] - Transactions must be based on forecasts of foreign currency receipts and payments, and the amounts involved should not exceed these forecasts [2][3] Chapter 3: Approval Procedures - All foreign exchange derivative transactions require board approval, especially those exceeding 20% of the latest audited net assets or 50 million yuan [3][4] - The management is responsible for executing transactions within the approved limits [4] Chapter 4: Information Disclosure - The company’s securities department is responsible for ensuring compliance with disclosure requirements related to foreign exchange derivative trading [5][6] - Any significant risks or losses must be disclosed promptly through temporary announcements [5] Chapter 5: Information Isolation Measures - All personnel involved in foreign exchange derivative trading must adhere to confidentiality protocols [6] Chapter 6: Internal Risk Reporting and Management Procedures - The company must implement measures to assess and mitigate risks associated with foreign exchange derivative trading [7] - The finance department is tasked with monitoring market prices and evaluating risks related to counterparties [7][8] Chapter 7: Supplementary Provisions - Any matters not covered by these regulations will be governed by relevant national laws and regulations [8]
广康生化: 华泰联合证券有限责任公司关于广东广康生化科技股份有限公司继续开展外汇衍生品交易业务的核查意见
Zheng Quan Zhi Xing· 2025-08-21 09:13
Core Viewpoint - The company, Guangdong Guokang Biochemical Technology Co., Ltd., aims to continue its foreign exchange derivatives trading to mitigate risks associated with currency fluctuations and enhance financial stability [1][10]. Group 1: Purpose of Foreign Exchange Derivatives Trading - The primary objective of engaging in foreign exchange derivatives trading is to effectively hedge against foreign exchange market risks and prevent adverse impacts from significant currency fluctuations [1]. - The company plans to engage with qualified banks and financial institutions to conduct these transactions [1]. Group 2: Basic Details of the Trading Business - The company intends to utilize its own funds for foreign exchange derivatives trading, with a total limit not exceeding $50 million [2]. - The expected maximum margin and premium for these transactions will not exceed $4 million [2]. - The trading will involve currencies used in the company's overseas operations, primarily the US dollar, and will include various products such as forward foreign exchange settlements, foreign exchange swaps, and options [1][2]. Group 3: Risk Management Measures - The company will adhere to principles of legality, prudence, safety, and effectiveness in its trading activities, avoiding speculative transactions [4][8]. - A clear set of operational norms, approval authorities, and risk management procedures will be established to control trading risks [8]. Group 4: Impact on the Company - The foreign exchange derivatives trading is closely related to the company's operational activities, enhancing its ability to manage foreign exchange risks and reducing financial costs [5][10]. - The trading activities are expected to strengthen the company's financial stability without harming the interests of the company or its shareholders [5][10]. Group 5: Accounting Policies and Procedures - The company will follow relevant accounting standards for financial instruments and hedge accounting to reflect the transactions in its financial statements [9]. Group 6: Approval Process - The board of directors approved the continuation of foreign exchange derivatives trading on August 20, 2025, with the authorization effective from September 23, 2025, for a period of 12 months [9][10]. - The audit committee has confirmed the necessity and compliance of the decision-making process regarding the trading activities [10].
广康生化拟开展不超5000万美元外汇衍生品交易业务
Xin Lang Cai Jing· 2025-08-21 08:36
Core Viewpoint - Guangkang Biochemical (300804) has approved the continuation of foreign exchange derivative trading, with a total limit of up to 50 million USD for the next 12 months, starting from September 23 [1] Group 1: Business Operations - The company plans to use its own funds for foreign exchange derivative trading, primarily involving USD, through methods such as forward foreign exchange contracts [1] - The previous authorization for this trading activity is set to expire on September 23, and the new authorization will be effective for 12 months with funds being reusable [1] Group 2: Risk Management - The company acknowledges potential risks associated with market fluctuations and exchange rate volatility, and has established corresponding management measures to mitigate these risks [1] - The trading business is closely related to the company's operations and is expected to enhance financial stability [1] Group 3: Governance and Approval - The proposal has been approved by the board of directors and the audit committee, with no objections from the sponsor [1]
浙江东南网架股份有限公司 第八届董事会第二十五次会议决议公告
Zheng Quan Shi Bao· 2025-08-19 19:54
Core Viewpoint - The company has approved a plan to engage in foreign exchange derivative hedging to mitigate risks associated with currency fluctuations, enhancing financial stability while ensuring that core business operations remain unaffected [3][12][25]. Group 1: Board Meeting Details - The company's 25th meeting of the 8th Board of Directors was held on August 19, 2025, with all 9 directors present, confirming the legality and validity of the meeting [2][3]. - The board unanimously approved the proposal for foreign exchange derivative hedging with a vote of 9 in favor, 0 against, and 0 abstentions [3][4]. Group 2: Foreign Exchange Derivative Hedging Proposal - The company plans to conduct foreign exchange derivative hedging with a maximum transaction amount of up to $80 million or equivalent foreign currency, which can be rolled over within a 12-month period [3][12][15]. - The hedging activities are aimed at preventing adverse impacts from foreign currency exchange rate fluctuations and enhancing the company's financial resilience [12][14]. Group 3: Monitoring and Risk Management - The company has established a comprehensive risk management framework to monitor foreign exchange market conditions and adjust strategies accordingly to minimize potential losses [22]. - The financial department will oversee all foreign exchange derivative transactions, ensuring they are based on actual business needs and not speculative in nature [22][23]. Group 4: Compliance and Approval Process - The proposal for foreign exchange derivative hedging was reviewed and approved by both the Board of Directors and the Supervisory Board, confirming compliance with relevant laws and regulations [19][20][25]. - The company has developed a specific management system for foreign exchange derivative transactions to ensure adherence to regulatory requirements and internal controls [4][25].
安凯微: 广州安凯微电子股份有限公司第二届董事会第十四次会议决议公告
Zheng Quan Zhi Xing· 2025-08-13 16:23
证券代码:688620 证券简称:安凯微 公告编号:2025-044 广州安凯微电子股份有限公司 第二届董事会第十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 广州安凯微电子股份有限公司(以下简称"公司")第二届董事会第十四次会 议于 2025 年 8 月 12 日 10:30-11:00 在公司会议室以现场与通讯相结合的方式召开。 本次会议的通知已于 2025 年 8 月 1 日以通讯方式送达公司全体董事。本次会议由公 司董事长 NORMAN SHENGFA HU(胡胜发)[以下简称"胡胜发"]先生主持,会 议应出席董事 7 名,实际出席董事 7 名。本次会议的召集、召开和表决程序符合 《中华人民共和国公司法》(以下简称"《公司法》")等法律、法规、规范性文件 和《广州安凯微电子股份有限公司章程》(以下简称"《公司章程》")、《广州安凯 微电子股份有限公司董事会议事规则》的规定,会议决议合法、有效。 二、董事会会议审议情况 (一)审议通过《关于2025年半年度报告及其摘要的议案 ...
安凯微: 国泰海通证券股份有限公司关于广州安凯微电子股份有限公司开展外汇衍生品交易业务的核查意见
Zheng Quan Zhi Xing· 2025-08-13 12:19
Core Viewpoint - The company intends to conduct foreign exchange derivative trading to mitigate currency and interest rate risks due to increasing foreign exchange inflows and outflows as its business expands [1][2]. Summary by Sections Transaction Overview - The purpose of the transaction is to effectively hedge against exchange rate and interest rate risks, enhancing the company's financial stability [1]. - The total trading limit for foreign exchange derivatives is set at a maximum of $10 million, with a margin and premium cap of $10 million, valid for 12 months from the board's approval [1]. - The funding for these transactions will come from the company's own and borrowed funds, without involving raised capital [2]. - The trading methods include foreign exchange swaps, options, interest rate swaps, and structured forwards, with no offshore derivative trading planned [2]. - The validity of the trading limit is effective for 12 months from the board's approval date [2]. Review Procedures - The company held board and supervisory meetings on August 12, 2025, to approve the foreign exchange derivative trading proposal, which does not require shareholder approval [2]. Risk Analysis and Control Measures - The potential risks include market risk from derivative trading losses, internal control weaknesses, and operational risks due to system failures or improper handling of derivative information [2]. - The company has established clear regulations regarding trading limits, types, approval authority, internal review processes, and risk management to mitigate these risks [2][3]. Impact on the Company and Accounting Treatment - Engaging in foreign exchange derivative trading aims to enhance the company's ability to manage foreign exchange volatility risks, thereby protecting profits and shareholder equity [3]. - The company will account for these transactions in accordance with relevant accounting standards, reflecting the impacts on the balance sheet and income statement [3]. Sponsor's Review Opinion - The sponsor has confirmed that the company has followed necessary approval procedures for the foreign exchange derivative trading business, and there are no adverse effects on the company or its shareholders [3][4].
比亚迪: 第八届董事会第十九次会议决议公告
Zheng Quan Zhi Xing· 2025-08-01 16:36
Core Viewpoint - BYD Company Limited has made significant changes to its registered capital and has approved an increase in its foreign exchange derivatives trading limit, reflecting its strategic growth and financial management initiatives [1][2]. Group 1: Changes in Registered Capital - The company held its 19th meeting of the 8th Board of Directors, where it was decided to change the registered capital and amend the Articles of Association [1]. - The company approved a profit distribution plan, which includes a cash dividend of RMB 39.74 per 10 shares (including tax) and a stock dividend of 8 shares for every 10 shares held, resulting in a total cash dividend of approximately RMB 12,077.248 million [1]. - Following the implementation of the profit distribution plan, the total number of shares increased from 3,039.065855 million to 9,117.197565 million, and the registered capital rose from RMB 3,039.065855 million to RMB 9,117.197565 million [1]. Group 2: Foreign Exchange Derivatives Trading - The Board of Directors approved a feasibility analysis report for increasing the foreign exchange derivatives trading limit, which does not require shareholder meeting approval [2]. - The trading limit for foreign exchange derivatives will be increased from the equivalent of USD 10 billion to USD 12 billion, with a usage period of 12 months from the date of approval [2]. - The approved limit can be used on a revolving basis, with the maximum investment balance at any point not exceeding USD 12 billion, and the expected credit limit usage not exceeding USD 600 million [2].
思看科技(杭州)股份有限公司 关于选举第二届董事会职工代表董事的公告
Sou Hu Cai Jing· 2025-08-01 16:28
Group 1 - The company has elected a new employee representative director, Ms. Zhu Xiaojuan, to the second board of directors, which will serve a term of three years starting from the approval date of the second extraordinary general meeting of shareholders in 2025 [1][6][7] - The second board of directors consists of three non-independent directors and three independent directors, along with the employee representative director, ensuring that the number of employee representatives does not exceed half of the total board members [2][7] - The company has decided to abolish the supervisory board, transferring its powers to the audit committee of the board of directors [14] Group 2 - The company has authorized its management to conduct foreign exchange derivative trading to mitigate risks associated with exchange rate fluctuations, with a total limit of up to $15 million or its equivalent in RMB [22][23] - The foreign exchange derivative trading will be conducted using the company's own funds and will not involve speculative trading [25][26] - The company has established risk control measures to manage potential risks associated with foreign exchange derivative trading, including careful selection of trading partners and adherence to relevant laws and regulations [31][32]